Finasteride
Top View
- Safety of 5Α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies
- Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies
- Finasteride (Propecia)
- Modulating the Heat Sensitivity of Prostate Cancer Cell Lines in Vitro: a New Impact for Focal Therapies
- Addressing Androgenetic Alopecia‒A Complex Disorder‒With a Multilateral Treatment Strategy
- Literature Review Update Treatment of Male Androgenetic Alopecia
- Finasteride Side Effects and Post-Finasteride Syndrome in Male
- Efficacy of Non‐Surgical Treatments for Androgenetic Alopecia
- PROPECIA® (Finasteride) Tablets, 1 Mg
- A Comparison Between Spironolactone and Spironolactone Plus
- Efficacy and Safety of Finasteride (5 Alpha-Reductase Inhibitor
- Suppressive Effects of Antiandrogens, Finasteride and Flutamide on Development of Prostatic Lesions in a Transgenic Rat Model
- PROPECIA Safely and Effectively
- Female Pattern Hair Loss: a Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone
- Phytochemicals with Anti 5-Alpha-Reductase Activity: A
- Finasteride | Memorial Sloan Kettering Cancer Center
- Ketocazole As an Adjunct to Finasteride in the Treatment Of
- Finasteride Treatment of Female Pattern Hair Loss